These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33576504)

  • 1. Evaluation of barriers to therapeutic drug monitoring in the management of hidradenitis suppurativa.
    Hilerowicz Y; Levin NJ; Parmar J; Halavi A; Lev-Tov H
    Clin Exp Dermatol; 2021 Jul; 46(5):936-938. PubMed ID: 33576504
    [No Abstract]   [Full Text] [Related]  

  • 2. Low prescription of tumor necrosis alpha inhibitors in hidradenitis suppurativa: A cross-sectional analysis.
    Orenstein LAV; Wright S; Strunk A; Garg A
    J Am Acad Dermatol; 2021 May; 84(5):1399-1401. PubMed ID: 32758630
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hidradenitis suppurativa: a U.K. survey of current practice.
    Ingram JR; McPhee M
    Br J Dermatol; 2015 Oct; 173(4):1070-2. PubMed ID: 25913663
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain.
    Jedrzejczak MJ; Ingram JR; Lowes MA; Naik HB; McKenzie-Brown AM; Chen SC; Orenstein LAV
    JAMA Dermatol; 2021 Apr; 157(4):464-466. PubMed ID: 33625467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of hidradenitis suppurativa.
    Orenstein LA; Micheletti RG
    Semin Cutan Med Surg; 2017 Jun; 36(2):62-66. PubMed ID: 28538746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa scoring systems: can we choose just one?
    Porter ML; Kimball AB
    Cutis; 2017 Mar; 99(3):156-157. PubMed ID: 28398416
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and management of hidradenitis suppurativa in women.
    Collier EK; Parvataneni RK; Lowes MA; Naik HB; Okun M; Shi VY; Hsiao JL
    Am J Obstet Gynecol; 2021 Jan; 224(1):54-61. PubMed ID: 32980357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis suppurativa for the dermatologic hospitalist.
    Charrow A; Savage KT; Flood K; Kimball AB
    Cutis; 2019 Nov; 104(5):276-280. PubMed ID: 31886786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
    Lam J; Krakowski AC; Friedlander SF
    Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

  • 12. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
    Moyano B; Clemente A; Marín-Jiménez I; Martorell A
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical management and wound care approaches for hidradenitis suppurativa.
    Antia C; Alavi A; Alikhan A
    Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.